ExodusPoint Capital Management’s Adaptimmune Therapeutics ADAP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-370,288
| Closed | -$398K | – | 1534 |
|
|
2022
Q3 | $398K | Buy |
370,288
+70,288
| +23% | +$75.5K | 0.01% | 1409 |
|
|
2022
Q2 | $510K | Buy |
+300,000
| New | +$510K | 0.01% | 1291 |
|
|
2021
Q4 | – | Sell |
-86,202
| Closed | -$446K | – | 2074 |
|
|
2021
Q3 | $446K | Buy |
+86,202
| New | +$446K | 0.01% | 1414 |
|
|
2021
Q1 | – | Sell |
-76,920
| Closed | -$415K | – | 2018 |
|
|
2020
Q4 | $415K | Buy |
76,920
+46,313
| +151% | +$250K | ﹤0.01% | 1286 |
|
|
2020
Q3 | $244K | Buy |
+30,607
| New | +$244K | ﹤0.01% | 1328 |
|